Goldentree Asset Management LP's Form 4 filing
Keenova Therapeutics plc (MNKTQ) · filed Feb 20, 2024
- Accession no.
- 0001493152-24-007242
- Filed
- Feb 20, 2024, 5:00 PM ET
- Trade date
- Feb 15, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $8.61M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goldentree Asset Management LPCIK 0001278951 | 10% Owner |
| Tananbaum Steven A.CIK 0001435626 | 10% Owner |
| GoldenTree Asset Management LLCCIK 0001435627 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2024 | Ordinary Shares | PPurchaseAcquired | +225,000 | $38.25 | +$8,606,250 | 2,316,035 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.